|
+16
|
Is Equity Research Still a Good Career Path in 2026?
|
3h |
|
0
|
Exploding Offer - Should I Still Recruit for ER?
|
23h |
|
+9
|
Technical/Data Background → Semiconductor Equity Research: Built an AVGO Earnings Model and Would Appreciate ER Feedback
|
1d |
|
0
|
The Silent Inflection Point in U.S. Power Infrastructure
|
2d |
|
0
|
ER FT Recruiting Timeline
|
2d |
|
+3
|
London ER recruiters
|
3d |
|
+9
|
Anyone recently interviewed for Bloomberg Intelligence Equity Research?
|
4d |
|
0
|
D.E Shaw Fundamental Research
|
4d |
|
+9
|
VP shortlist at current shop vs. signed BB offer — thoughts?
|
5d |
|
|
|
0
|
Goldman SA ER 2027?
|
6d |
|
0
|
Who would you hire out of these two?
|
1w |
|
+1
|
London BofA Global research (ER) SA 2027
|
1w |
|
+14
|
Deleted
|
1w |
|
+23
|
Advice on remembering massive amount of data
|
1w |
|
+3
|
Found this really interesting equity report on X
|
1w |
|
+6
|
Recruiting season questions, rising sophomore @ Kelley
|
1w |
|
+27
|
Integrating Claude into your process
|
2w |
|
+2
|
What is it like working in BD at a pod?
|
2w |
|
+9
|
What are the best paths into equity research through a life sciences undergrad?
|
2w |
|
+8
|
Is AI finally starting to kill Equity Research?
|
2w |
|
+14
|
Pivot from Top European Engineering to Equity Research: Strategy Review
|
2w |
|
+30
|
Struggling on my internship
|
2w |
|
+6
|
Ramesh Deonaraine
|
2w |
|
0
|
Upside of ER?
|
2w |
|
|
|
+49
|
Q&A - Equity Research
|
2w |
|
0
|
Cleveland Research Company
|
3w |
|
+50
|
Are any ER juniors actually happy?
|
3w |
|
+6
|
Do you have what it takes to be a good publishing analyst?
|
3w |
|
+14
|
How do you actually trace second-order effects after a market event?
|
3w |
|
+15
|
How do you actually build your football fields — CapIQ, template, or from scratch?
|
3w |
|
+39
|
Why do you want to be a sector-lead analyst?
|
3w |
|
+3
|
ER Modeling & Writing Test - Advice?
|
4w |
|
+22
|
Started ER Internship, Reconsidering: Exit Opps?
|
4w |
|
+3
|
ER Interview
|
4w |
|
+18
|
ER - Intern and Full Time QBank Technical Questions
|
4w |
|
+33
|
Best MSF for ER
|
4w |
|
+3
|
Superday - Modeling & Writing 2 hour test, advice or models you could send
|
1mo |
|
+4
|
Generalist vs specialist focus if end goal is L/S
|
1mo |
|
+42
|
FT Networking: Better To Be Direct Or Indirect?
|
1mo |
|
+2
|
Buy side ER case study
|
1mo |
|
+5
|
London MS ER SA 2027
|
1mo |
|
+10
|
Which masters after Equity Research
|
1mo |
|
+22
|
Full-Time Equity Research Recruiting
|
1mo |
|
0
|
Are there still openings for ER summer 27 out there or are most of them closed
|
1mo |
|
+123
|
Calling All Former ER: Where Did You Go?
|
1mo |
|
0
|
Healthcare (HC) Primers / Resources
|
1mo |
|
+25
|
ER outlook
|
1mo |
|
+2
|
Biotech // Therapeutics ER Comp
|
1mo |
|
0
|
I truly don’t know what to do
|
1mo |
|
0
|
GS Dubai Off Cycle (GIR/Equity Research) - Anyone heard back?
|
1mo |
|
+3
|
ER o&g interview process
|
1mo |
|
+6
|
Trying to prepare for upcoming soph year
|
1mo |
|
+6
|
Advice for a new associate?
|
1mo |
|
+13
|
ER--Unusually long reference checks post-superday
|
1mo |
|
0
|
Preliminary Analysis of Toast
|
1mo |
|
+6
|
Networking During My Internship
|
1mo |
|
+8
|
Biopharma ER?
|
2mo |
|
+15
|
Built a desktop valuation app (DCF / DDM / reverse DCF) so I'd stop rebuilding Excel models for every pitch — would value some ER feedback
|
2mo |
|
+8
|
Why hire an equity analyst if AI can write the reports
|
2mo |
|
0
|
MLP Equities Analyst Program Update
|
2mo |
|
+18
|
Former Pharma scientist with sell-side biotech ER experience — interview processes keep stalling, what am I missing
|
2mo |
|
0
|
Insurance investing conferences?
|
2mo |
|
+35
|
Does anyone else find it very difficult to take vacations in ER?
|
2mo |
|
+11
|
PayPal (PYPL): Why Is the Market Valuing PayPal Like a Low-Growth Company Despite Strong Free Cash Flow?
|
2mo |
|
0
|
Resources to Find Info on Modeling a Biotech Company
|
2mo |
|
0
|
Rising Senior in ER feeling lost/FT advice
|
2mo |
|
+16
|
Intel (INTC): My Bull Case Still Doesn't Justify the Current Stock Price
|
2mo |
|
0
|
JPM Equity Research SA27
|
2mo |
|
+11
|
Thoughts on boutique ER firm opportunity and options afterwards
|
2mo |
|
0
|
JPM Equity Research SA27?
|
2mo |
|
+9
|
Rising Sophomore clueless about recruiting timeline
|
2mo |
|
+7
|
Irenic Latest Views?
|
2mo |
|
+14
|
Rising junior at semi-target, fumbled sophomore recruiting — how cooked am I really?
|
2mo |
|
+9
|
Is equity research dead? If not, what aspects are still viable?
|
2mo |
|
+9
|
What is the best path for me as MBA student to HF
|
3mo |
|
+9
|
CC student, help choose schools
|
3mo |
|
+17
|
DB ER?
|
3mo |
|
+18
|
ER Pulse Check... How We Doing?
|
3mo |
|
+17
|
Equity Research Today: What skills are actually most valuable for entry-level analysts?
|
3mo |
|
+20
|
Article: UBS: The Fragile Facade of a Post-Merger Powerhouse
|
3mo |
|
+66
|
Best B-school for Equity Research
|
3mo |
|
0
|
Do these basically kills the need of an Sell Side associate?
|
3mo |
|
+6
|
GS Off-Cycle GIR
|
3mo |
|
+37
|
MD hates me, what do I do?
|
3mo |
|
+10
|
Automating Equity Research Workflows — From 2–3 Hours to ~20 Minutes
|
3mo |
|
+12
|
Bored on the buyside
|
3mo |
|
+3
|
Power & utilities primer / initiation?
|
3mo |
|
+15
|
ER Case Study guidance
|
3mo |
|
+9
|
Notes from JBL's Q2 Earnings Call: Margins, Capex, and the FY27 Bridge
|
4mo |
|
+15
|
ER 27 Timeline
|
4mo |
|
+12
|
Texas ER work life?
|
4mo |
|
0
|
Deriving Fixed/Variable Costs with Limited Disclosure
|
4mo |
|
+9
|
IB SA -> ER
|
4mo |
|
+9
|
Ford's CEO and CFO sounded exactly the same on the Q4 call. That's weird, right?
|
4mo |
|
+4
|
Best ER firms?
|
4mo |
|
0
|
SIG 2026 Full-time ER
|
4mo |
|
+9
|
Let go from LO cross-asset seat. How to position next move?
|
4mo |
|
+3
|
ESG Research Analyst > Investment Analyst in an ESG fund
|
4mo |
|
+1
|
ER (London) BB Comp 2026?
|
4mo |
|
+9
|
Bloomberg Intelligence vs Sell-Side Equity Research → Buyside Path?
|
4mo |
or Want to Sign up with your social account?